Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
We believe there will be three key themes for fixed income investors to focus on in the new year. Kevin Flanagan provides a brief synopsis on these themes and potential solutions for them in the fixed income universe.
The COVID-19 impact on the markets reared its ugly head over the last couple of weeks in the U.S. corporate bond market. Kevin Flanagan and Josh Shapiro provide investors with a solution to help avoid the pitfalls of corporate bond investing that seem to be getting highlighted on a daily basis in the current environment.
Given recent market volatility and geopolitical/economic concerns, we continue to lean into using sound, time-tested fundamental metrics to help navigate an uncertain future. With this approach, investors have the potential to avoid volatility risk, while preserving the potential to earn higher levels of income and participate in a growing part of the economy.
Few markets or asset classes were spared when volatility returned with a vengeance. We discuss what recent moves have meant for U.S. high-yield bonds and why our fundamental approach to credit has outperformed all other credit ETFs and the majority of active managers.